NASDAQ:IDYA

ASCO·Biotechnology·NASDAQ:IDYA·News·Trading Insights

IDEAYA Holds Steady Heading Into ASCO—Traders Watch for Next Mover on IDYA

IDEAYA Biosciences shares closed at $29.47 Friday, up 1.3% for the shortened week. The company will present full OptimUM-02 trial data for darovasertib at ASCO on June 1. IDEAYA granted 221,000 stock options to six new hires, priced at $29.34. U.S. markets closed for Memorial Day and will reopen Monday.

May 31, 2026

Lloyds Banking Group Shares Poised for 15% Growth in June, Analysts Say
May 31, 2026, 9:30 AM EDT. Analysts forecast Lloyds Banking Group (LSE: LLOY) shares to rise around 15% from current levels, with an average price target of 115p. The stock has already surged 32% in 12 months and 103% over five years. Lloyds' 2026 guidance includes net interest income exceeding £14.9 billion, a cost-to-income ratio under 50%, and a return on tangible equity above 16%, underpinning its valuation around a forward price-to-earnings ratio of 10. Market watchers await the bank's first-half earnings update on July 30, which may catalyse further movement. Additionally, Lloyds' planned expansion into U.S. infrastructure and data centre investments, tied to artificial intelligence trends, has sparked investor interest, potentially boosting share prices in the near term.